Skip to main navigation
InVivo Therapeutics

Invivo - Investor Relations

  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Unmet Need
  • Physicians
  • Investors & Media
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • SEC Filings
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Board Diversity Matrix
    • Investor FAQs
    • Email Alerts

Invivo - Investor Relations

  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Unmet Need
  • Physicians
  • Investors & Media
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • SEC Filings
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Board Diversity Matrix
    • Investor FAQs
    • Email Alerts

Press Releases

Press Releases

Date Title  
July 13, 2022
InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel
June 8, 2022
InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery
June 2, 2022
InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
April 14, 2022
InVivo Therapeutics Announces Reverse Stock Split
January 6, 2022
InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference

Invivo - Investor Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR

© 2022 Invivo Therapeutics

Invivo - Site Footer Menu

  • Privacy Policy
  • Terms of Service
  • Subscribe
  • Twitter
  • Facebook
  • LinkedIn